ImmunityBio, Inc. 10-K

ITEM 2. PROPERTIES. We lease property in multiple facilities across the U.S. and Italy, including facilities located in El Segundo and Culver City, CA that are leased from related parties. See Note 11 , Related-Party Agreements , of the “Notes to Consolidated Financial Statements” that appears in Part II, Item 8. “Financial Statements and Supplementary Data” of this Annual Report for more information about our related-party leases. The following table summarizes our principal properties under lease as of December 31, 2023: Location Expiration Year (1) Approximate Rentable Square Feet (2) Primary Function(s) United States Dunkirk, NY 2031 409,000 Future Manufacturing Facility El Segundo, CA 2026 – 2029 132,136 Laboratory – Research & Manufacturing Louisville, CO 2025 50,838 Laboratory – Research Culver City, CA Month to Month 46,330 Laboratory – Research & Manufacturing San Diego, CA 2030 44,681 Laboratory – Research & Corporate Office Woburn, MA 2025 8,153 Laboratory – Research & Office Seattle, WA 2025 5,527 Laboratory – Research International Italy 2024 – 2028 15,748 Laboratory – Research & Office _______________ (1) Expiration years shown are per the lease agreements in effect as of December 31, 2023 and do not reflect contractual options to extend the term of the lease available to us under the lease agreements. For locations with multiple leases, the first and last expiration year are shown. (2) Amounts shown represent the total approximate rentable square feet for all buildings located in each city. We believe that our existing facilities are adequate to meet our current and future needs and that we will be able to renew existing leases and obtain additional commercial space as needed.